Exact Mass: 604.3584

SAPONIN K3

C35H56O8 (604.3975)

Hederagenin 3-O-arabinoside is a triterpenoid saponin that is hederagenin attached to an alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. It has a role as a plant metabolite. It is a triterpenoid saponin, a monosaccharide derivative, a pentacyclic triterpenoid, a hydroxy monocarboxylic acid and an alpha-L-arabinopyranoside. It is functionally related to a hederagenin. It derives from a hydride of an oleanane. Cauloside A is a natural product found in Lonicera japonica, Hedera caucasigena, and other organisms with data available. See also: Caulophyllum robustum Root (part of). A triterpenoid saponin that is hederagenin attached to an alpha-L-arabinopyranosyl residue at position 3 via a glycosidic linkage. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2]. Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2].

3-Epipapyriferic acid

C35H56O8 (604.3975)

3-Epipapyriferic acid is a constituent of silver birch (Betula pendula) bark resin, used in manufacture of sweet birch oil. Constituent of silver birch (Betula pendula) bark resin, used in manuf. of sweet birch oil

[(S)-1-Carboxy-2-phenyl-ethyl]-carbamoyl-Arg-Val-Arg-aldehyde

C27H44N10O6 (604.3445)

Telinavir

C33H44N6O5 (604.3373)

PA(10:0/18:1(12Z)-O(9S,10R))

C31H57O9P (604.374)

PA(10:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-O(9S,10R)/10:0)

C31H57O9P (604.374)

PA(18:1(12Z)-O(9S,10R)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/10:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:1(9Z)-O(12,13))

C31H57O9P (604.374)

PA(10:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/10:0)

C31H57O9P (604.374)

PA(18:1(9Z)-O(12,13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/10:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

ZiyuglycosideII

C35H56O8 (604.3975)

ziyuglycoside II is a natural product found in Sanguisorba officinalis with data available. Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1]. Ziyuglycoside II is a triterpenoid saponin compound extracted from Sanguisorba officinalis L.. Ziyuglycoside II induces reactive oxygen species (ROS) production and apoptosis. Anti-inflammation and anti-cancer effect[1].

Belamide A

C35H48N4O5 (604.3625)

Lasalocid C

C35H56O8 (604.3975)

Periplocoside M

C34H52O9 (604.3611)

Sublanceoside B1

C33H48O10 (604.3247)

Lasalocid E

C35H56O8 (604.3975)

luvungin D

C34H52O9 (604.3611)

3beta-p-Hydroxybenzoyldehydrotumulosic acid

C38H52O6 (604.3764)

Caseamembrin D

C33H48O10 (604.3247)

Tiacumicin A

C34H52O9 (604.3611)

Lasalocid B

C35H56O8 (604.3975)

Mezzettiaside 9

C30H52O12 (604.3459)

Luvungin G

C34H52O9 (604.3611)

Lasalocid D

C35H56O8 (604.3975)

Viridominic acid B

C33H48O10 (604.3247)

KS 501

C33H48O10 (604.3247)

Antipain

C27H44N10O6 (604.3445)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

aeruginosin 298-A

C30H48N6O7 (604.3584)

papyriferic acid

C35H56O8 (604.3975)

HMR1171

C35H48N4O3S (604.3447)

methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate

C33H48O10 (604.3247)

1alpha-hydroxycycloartenoid mollic acid 3beta-D-xyloside|mollic acid xyloside

C35H56O8 (604.3975)

rotundifolic acid

C35H56O8 (604.3975)

C33H48O10

C33H48O10 (604.3247)

Prosapogenin CP0

C35H56O8 (604.3975)

3-O-alpha-L-Arabinopyranoside-Cochalic acid

C35H56O8 (604.3975)

3beta,24-dihydroxyurs-12-en-28-oic acid-24-O-beta-D-xylopyranoside

C35H56O8 (604.3975)

21-Angeloyl-12-Oleanene-3,15,16,21,22,24,28-heptol

C35H56O8 (604.3975)

pulsatilloside A

C35H56O8 (604.3975)

3??-[(??-L-Arabinopyranosyl)oxy]-19??-hydroxyurs-12-en-28-oic acid

C35H56O8 (604.3975)

(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C

C38H52O6 (604.3764)

SCHEMBL22747739

C35H56O8 (604.3975)

3-O-??-L-Arabinopyranosyl-23-hydroxyursolic acid

C35H56O8 (604.3975)

C35H56O8

C35H56O8 (604.3975)

Cyclocarioside II

C35H56O8 (604.3975)

hippuristerol C

C35H56O8 (604.3975)

Bafilomycin D

C35H56O8 (604.3975)

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

C38H52O6 (604.3764)

27-hydroxyursolic acid 3-O-alpha-L-arabinopyranoside

C35H56O8 (604.3975)

Tetra-Ac-(3beta, 5alpha, 6alpha, 15alpha, 24?鈥?-Cholestane-3, 6, 15, 24-tetrol

C35H56O8 (604.3975)

Ilexoside A

C35H56O8 (604.3975)

14-acetoxy-3,14-dihydroimplexin

C33H48O10 (604.3247)

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

C38H52O6 (604.3764)

zizyotin

C35H56O8 (604.3975)

pedunculol

C38H52O6 (604.3764)

junceelloside E

C35H56O8 (604.3975)

anagalligenone-3-O-alpha-L-arabinopyranoside

C35H56O8 (604.3975)

Xanthochymol

C38H52O6 (604.3764)

pelargoside B1

C30H52O12 (604.3459)

C30H52O12

C30H52O12 (604.3459)

14beta-hydrogen-(20S,22R)-22,26-epoxy-27-[(beta-glucopyranosyl)oxy]ergosta-2,4,6,24-tetraene-1,26-dione|baimantuoluoside H

C34H52O9 (604.3611)

3beta-O-beta-D-glucopyranosyloxy-5alpha-stigmasta-7,9(11),24(28)Z-triene-16beta,29-diol

C35H56O8 (604.3975)

20-O-alpha-L-arabinopyranosyl jujubogenin

C35H56O8 (604.3975)

biselyngbyaside

C34H52O9 (604.3611)

(1R*,3S*,5S*,6aR*,7R*,8R*,9S*,10S*,10aR*)-1,10-bis(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]-3,5,6,6a,7,8,9,10-octahydronaphtho[1,8a-c]furan-3,9-diyl dibutanoate

C33H48O10 (604.3247)

mollic acid 3-O-beta-D-xyloside

C35H56O8 (604.3975)

3-methyl-6-{7-ethyl-4-hydroxy- 3,5-dimethyl-6-oxo-7-[5-ethyl-3-methyl-5-(5-ethyl-5-hydroxy-6-methyl-2-tetrahydropyranyl)-2-tetrahydrofuryl]heptyl}salicylic acid, methyl ester

C35H56O8 (604.3975)

(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate

C38H52O6 (604.3764)

caseamembrin R|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2-(2-methylbutanoyloxy)-18-butanoyloxy-7,19-diacetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene

C33H48O10 (604.3247)

stemphone F

C33H48O10 (604.3247)

3-O-[alpha-L-arabinopyranosyl]pseudojujubogenin|bacopasaponin H

C35H56O8 (604.3975)

11beta-Alcohol, Me ester-Viridominic acid A

C34H52O9 (604.3611)

physagulin

C34H52O9 (604.3611)

Casearin N

C33H48O10 (604.3247)

aplysioviolin

C34H44N4O6 (604.3261)

cryptophycin 4|Cryptophycin D|cryptophycin-4

C35H44N2O7 (604.3148)

anemoclemoside A

C35H56O8 (604.3975)

hederagenin 3-O-alpha-L-arabinopyranoside

C35H56O8 (604.3975)

(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B

C38H52O6 (604.3764)

hederagenin 3-O-alpha-L-arabinoside

C35H56O8 (604.3975)

Lys Asn Lys Glu Ser

C24H44N8O10 (604.318)

Gly Leu Arg Val Phe

C29H48N8O6 (604.3697)

Ile Thr Ser Arg Glu

C24H44N8O10 (604.318)

Arg Thr Leu Ser Asp

C24H44N8O10 (604.318)

Ile Val Ile Phe Asn

C30H48N6O7 (604.3584)

(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

C33H48O10_(2alpha,5alpha,9alpha,10beta,14beta)-2,5,9,10-Tetraacetoxytaxa-4(20),11-dien-14-yl 2-methylbutanoate

C33H48O10 (604.3247)

(3S,5R,7R,8R,9S,10S,13S,14S,16R,17R)-17-((2R)-7-acetoxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triyl triacetate

C35H56O8 (604.3975)

Phe Pro Arg Trp

C31H40N8O5 (604.3122)

Phe Pro Trp Arg

C31H40N8O5 (604.3122)

Phe Arg Pro Trp

C31H40N8O5 (604.3122)

Phe Arg Trp Pro

C31H40N8O5 (604.3122)

Phe Trp Pro Arg

C31H40N8O5 (604.3122)

Phe Trp Arg Pro

C31H40N8O5 (604.3122)

His His Arg Arg

C24H40N14O5 (604.3306)

His Arg His Arg

C24H40N14O5 (604.3306)

His Arg Arg His

C24H40N14O5 (604.3306)

Ile Met Arg Trp

C28H44N8O5S (604.3155)

Ile Met Trp Arg

C28H44N8O5S (604.3155)

Ile Arg Met Trp

C28H44N8O5S (604.3155)

Ile Arg Trp Met

C28H44N8O5S (604.3155)

Ile Trp Met Arg

C28H44N8O5S (604.3155)

Ile Trp Arg Met

C28H44N8O5S (604.3155)

Leu Met Arg Trp

C28H44N8O5S (604.3155)

Leu Met Trp Arg

C28H44N8O5S (604.3155)

Leu Arg Met Trp

C28H44N8O5S (604.3155)

Leu Arg Trp Met

C28H44N8O5S (604.3155)

Leu Trp Met Arg

C28H44N8O5S (604.3155)

Leu Trp Arg Met

C28H44N8O5S (604.3155)

Met Ile Arg Trp

C28H44N8O5S (604.3155)

Met Ile Trp Arg

C28H44N8O5S (604.3155)

Met Leu Arg Trp

C28H44N8O5S (604.3155)

Met Leu Trp Arg

C28H44N8O5S (604.3155)

Met Arg Ile Trp

C28H44N8O5S (604.3155)

Met Arg Leu Trp

C28H44N8O5S (604.3155)

Met Arg Trp Ile

C28H44N8O5S (604.3155)

Met Arg Trp Leu

C28H44N8O5S (604.3155)

Met Trp Ile Arg

C28H44N8O5S (604.3155)

Met Trp Leu Arg

C28H44N8O5S (604.3155)

Met Trp Arg Ile

C28H44N8O5S (604.3155)

Met Trp Arg Leu

C28H44N8O5S (604.3155)

Pro Phe Arg Trp

C31H40N8O5 (604.3122)

Pro Phe Trp Arg

C31H40N8O5 (604.3122)

Pro Arg Phe Trp

C31H40N8O5 (604.3122)

Pro Arg Trp Phe

C31H40N8O5 (604.3122)

Pro Trp Phe Arg

C31H40N8O5 (604.3122)

Pro Trp Arg Phe

C31H40N8O5 (604.3122)

Arg Phe Pro Trp

C31H40N8O5 (604.3122)

Arg Phe Trp Pro

C31H40N8O5 (604.3122)

Arg His His Arg

C24H40N14O5 (604.3306)

Arg His Arg His

C24H40N14O5 (604.3306)

Arg Ile Met Trp

C28H44N8O5S (604.3155)

Arg Ile Trp Met

C28H44N8O5S (604.3155)

Arg Leu Met Trp

C28H44N8O5S (604.3155)

Arg Leu Trp Met

C28H44N8O5S (604.3155)

Arg Met Ile Trp

C28H44N8O5S (604.3155)

Arg Met Leu Trp

C28H44N8O5S (604.3155)

Arg Met Trp Ile

C28H44N8O5S (604.3155)

Arg Met Trp Leu

C28H44N8O5S (604.3155)

Arg Pro Phe Trp

C31H40N8O5 (604.3122)

Arg Pro Trp Phe

C31H40N8O5 (604.3122)

Arg Arg His His

C24H40N14O5 (604.3306)

Arg Trp Phe Pro

C31H40N8O5 (604.3122)

Arg Trp Ile Met

C28H44N8O5S (604.3155)

Arg Trp Leu Met

C28H44N8O5S (604.3155)

Arg Trp Met Ile

C28H44N8O5S (604.3155)

Arg Trp Met Leu

C28H44N8O5S (604.3155)

Arg Trp Pro Phe

C31H40N8O5 (604.3122)

Trp Phe Pro Arg

C31H40N8O5 (604.3122)

Trp Phe Arg Pro

C31H40N8O5 (604.3122)

Trp Ile Met Arg

C28H44N8O5S (604.3155)

Trp Ile Arg Met

C28H44N8O5S (604.3155)

Trp Leu Met Arg

C28H44N8O5S (604.3155)

Trp Leu Arg Met

C28H44N8O5S (604.3155)

Trp Met Ile Arg

C28H44N8O5S (604.3155)

Trp Met Leu Arg

C28H44N8O5S (604.3155)

Trp Met Arg Ile

C28H44N8O5S (604.3155)

Trp Met Arg Leu

C28H44N8O5S (604.3155)

Trp Pro Phe Arg

C31H40N8O5 (604.3122)

Trp Pro Arg Phe

C31H40N8O5 (604.3122)

Trp Arg Phe Pro

C31H40N8O5 (604.3122)

Trp Arg Ile Met

C28H44N8O5S (604.3155)

Trp Arg Leu Met

C28H44N8O5S (604.3155)

Trp Arg Met Ile

C28H44N8O5S (604.3155)

Trp Arg Met Leu

C28H44N8O5S (604.3155)

Trp Arg Pro Phe

C31H40N8O5 (604.3122)

IVIFN

C30H48N6O7 (604.3584)

KFVLV

C31H52N6O6 (604.3948)

KNKES

C24H44N8O10 (604.318)

ITSRE

C24H44N8O10 (604.318)

3-Epipapyriferic acid

C35H56O8 (604.3975)

6-O-Linoleylsucrose

C30H52O12 (604.3459)

Telinavir

C33H44N6O5 (604.3373)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

(E)-5-hydroxy-2,2,6,6-tetramethylhept-4-en-3-one,manganese

C33H57MnO6 (604.3535)

4,5-Bis(dicyclohexylphosphino)-9,9-dimethyl-9H-xanthene

C39H58OP2 (604.3963)

2,7-Dihydroxy-3,6,10,11-tetrakis(pentyloxy)triphenylene

C38H52O6 (604.3764)

Spinosyn D 17-pseudoaglycone

C34H52O9 (604.3611)

N,N-Bis[4-(diethylamino)phenyl]-N,N-diethyl-1,4-benzenediamine hexafluorophosphate

C30H42N4.HPF6 (604.3129)

FR 139317

C33H44N6O5 (604.3373)

N~1~-{4-[(tert-Butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)aspartamide

C33H44N6O5 (604.3373)

Withalongolide M

C33H48O10 (604.3247)

A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.

Withalongolide N

C33H48O10 (604.3247)

A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.

Fruticoside C

C35H56O8 (604.3975)

A steroid saponin that is ergosta-7,24(28)-diene substituted by a hydroxy group at position 2, a methyl group at position 4, a carboxy group at position 21 and a alpha-L-quinovopyranosyloxy group at position 3 (the 2alpha,3beta,4alpha,5alpha stereoisomer). It has been isolated from the roots of Breynia fruticosa.

Cauloside A

C35H56O8 (604.3975)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2]. Cauloside A (Leontoside A) is a saponin isolated from Dipsacus asper roots. Cauloside A has potent antifungal activity[1][2].

[(1S,2R,3R,4S,5R)-5-azaniumyl-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-[(2S,3R,5S,6R)-3-azaniumyl-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxycyclohexyl]azanium

C23H50N5O13+5 (604.3405)

PA(10:0/18:1(12Z)-O(9S,10R))

C31H57O9P (604.374)

PA(18:1(12Z)-O(9S,10R)/10:0)

C31H57O9P (604.374)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C31H57O9P (604.374)

2-[[(2R)-3-acetyloxy-2-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)

2-[[(2R)-2-acetyloxy-3-[(6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H55NO9P+ (604.3614)

2-[[2-[[2-[[1-Azepanyl(oxo)methyl]amino]-4-methyl-1-oxopentyl]amino]-3-(1-methyl-3-indolyl)-1-oxopropyl]amino]-3-(2-pyridinyl)propanoic acid

C33H44N6O5 (604.3373)

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea

C35H48N4O5 (604.3625)

1-cyclohexyl-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea

C32H43F3N4O4 (604.3236)

(3S,5R,7R,8R,9S,10S,13S,14S,16R,17R)-17-((2R)-7-acetoxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triyl triacetate

C35H56O8 (604.3975)

[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14-trienyl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C31H57O9P (604.374)

(4S,5E,9E,11S,13E,15E,18R)-4-[(2R,3R,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-methoxyoxan-2-yl]oxy-8-methoxy-9,11-dimethyl-18-[(1Z,4E)-2-methylhexa-1,4-dienyl]-1-oxacyclooctadeca-5,9,13,15-tetraen-2-one

C34H52O9 (604.3611)

(5E,7R,8S,9S,11Z,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C30H53O10P (604.3376)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C30H53O10P (604.3376)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C30H53O10P (604.3376)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C30H53O10P (604.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C30H53O10P (604.3376)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C30H53O10P (604.3376)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C30H53O10P (604.3376)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C30H53O10P (604.3376)

(5E,7R,8S,9S,11E,13E,15S,16R)-16-[(E,2S,3R,4S,8S,9R)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

[1-phosphonooxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H49O8P (604.3165)

2-[[3-butanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

2-[[3-heptanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

2-[[3-acetyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

2-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H59NO8P+ (604.3978)

MGDG O-25:7

C34H52O9 (604.3611)

MGMG 25:7

C34H52O9 (604.3611)

DGGA 21:1;O

C30H52O12 (604.3459)

DGGA 22:0

C31H56O11 (604.3822)

PA O-16:0/12:3;O2

C31H57O9P (604.374)

PA O-20:0/8:3;O2

C31H57O9P (604.374)

PA O-27:4;O3

C30H53O10P (604.3376)

PA O-28:3;O2

C31H57O9P (604.374)

PA P-16:0/11:3;O3

C30H53O10P (604.3376)

PA P-16:0/12:2;O2

C31H57O9P (604.374)

PA P-20:0/7:3;O3

C30H53O10P (604.3376)

PA P-20:0/8:2;O2

C31H57O9P (604.374)

PA P-20:1/7:2;O3

C30H53O10P (604.3376)

PA P-20:1/8:1;O2

C31H57O9P (604.374)

PA 14:0/13:3;O2

C30H53O10P (604.3376)

PA 18:2/9:1;O2

C30H53O10P (604.3376)

PA 20:0/7:3;O2

C30H53O10P (604.3376)

PA 20:1/7:2;O2

C30H53O10P (604.3376)

PA 20:1/8:1;O

C31H57O9P (604.374)

PA 22:0/6:2;O

C31H57O9P (604.374)

PA 22:2/5:1;O2

C30H53O10P (604.3376)

PA 27:3;O2

C30H53O10P (604.3376)

PA 28:2;O

C31H57O9P (604.374)

LPGP O-20:1

C26H54O11P2 (604.3141)

LPGP P-20:0

C26H54O11P2 (604.3141)

PG O-24:4;O

C30H53O10P (604.3376)

PG P-16:0/8:3;O

C30H53O10P (604.3376)

PG P-18:1/6:2;O

C30H53O10P (604.3376)

PG 2:0_22:3

C30H53O10P (604.3376)

PG 20:2/4:1

C30H53O10P (604.3376)

PG 20:3/4:0

C30H53O10P (604.3376)

PG 24:3

C30H53O10P (604.3376)

PEth 26:2;O

C31H57O9P (604.374)

PEth 28:8

C33H49O8P (604.3165)

PM 27:2;O

C31H57O9P (604.374)

PM 29:8

C33H49O8P (604.3165)

ST 23:0;O7;GlcA

C29H48O13 (604.3095)

ST 27:4;O4;GlcA

C33H48O10 (604.3247)

ST 28:3;O3;GlcA

C34H52O9 (604.3611)

ST 29:2;O2;GlcA

C35H56O8 (604.3975)

ST 23:1;O8;Hex

C29H48O13 (604.3095)

ST 24:0;O7;Hex

C30H52O12 (604.3459)

ST 27:5;O5;Hex

C33H48O10 (604.3247)

ST 28:4;O4;Hex

C34H52O9 (604.3611)

ST 29:3;O3;Hex

C35H56O8 (604.3975)

Cyclic GMP (TBAOH)

C26H49N6O8P (604.3349)

Cyclic GMP TBAOH is a tetra-n-butylammonium hydroxide (TBAOH) form of Cyclic GMP (HY-12512). Cyclic GMP is an endogenous second messenger that regulates a variety of cellular processes including apoptosis, vasodilation, and neurotransmission through the activation of signaling pathways such as Protein Kinase G in cells[1].

(3s,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,13ar,13bs)-7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)

4-hydroxy-7,12,16-trimethyl-15-(6-methylhept-5-en-2-yl)-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C35H56O8 (604.3975)

(2s,4ar,4br,6ar,6bs,8as,12as,14ar,14br,16as)-4a,6a,6b,11,11,14b-hexamethyl-2-[(1r,2s,3s)-1,2,3,4-tetrahydroxybutyl]-2h,4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C35H56O8 (604.3975)

3-[(3s,3ar,5ar,6s,7s,9ar,9br)-3-[(2s,5s)-2-hydroxy-6-methyl-5-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-6-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,3ah,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoic acid

C35H56O8 (604.3975)

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11as)-11-(acetyloxy)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-(2-isopropyl-5-methylhex-4-en-1-yl)-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)

1-[2-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido)-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-4-hydroxy-7,12,16-trimethyl-15-[(2r)-6-methylhept-5-en-2-yl]-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C35H56O8 (604.3975)

(4as,6as,6br,10s,12ar,12br,14br)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

2-[2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s,4e)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(3e,5e,7r,8s,9s,11e,13e,15s)-16-[(2s,3r,4s,6e,8s,9r)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

(1s,3s,3ar,5s,6r,7s,7ar)-1-[(1r)-1-(acetyloxy)ethyl]-3,6-bis({[(2s)-2-methylbutanoyl]oxy})-4-methylidene-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-inden-5-yl (2e)-3-methylpent-2-enoate

C33H48O10 (604.3247)

3-heptyl-5-hydroxyphenyl 2-{[(2s,3r,4r)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

(4as,6as,6br,8ar,9r,10r,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN003259","Ingredient_name": "(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid","Alias": "(1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; (1S,4aR,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid","Ingredient_formula": "C35H56O8","Ingredient_Smile": "NA","Ingredient_weight": "604.81","OB_score": "11.7152079","CAS_id": "108529-23-3","SymMap_id": "SMIT09332","TCMID_id": "NA","TCMSP_id": "MOL007993","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α-(α-methylbutyryl)-oxy-5α,7β,9α,10β-tetra-acetoxy-4(20),11-taxadiene

C33H48O10 (604.3247)

{"Ingredient_id": "HBIN005275","Ingredient_name": "2\u03b1-(\u03b1-methylbutyryl)-oxy-5\u03b1,7\u03b2,9\u03b1,10\u03b2-tetra-acetoxy-4(20),11-taxadiene","Alias": "NA","Ingredient_formula": "C33H48O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3,23-dihydroxy-12-oleanen-28-oic acid; 3β-form,23-o-alpha-l-arabinopyranoside

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN007006","Ingredient_name": "3,23-dihydroxy-12-oleanen-28-oic acid; 3\u03b2-form,23-o-alpha-l-arabinopyranoside","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "NA","Ingredient_weight": "604.81","OB_score": "NA","CAS_id": "83864-75-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8410","PubChem_id": "NA","DrugBank_id": "NA"}

3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-olean-12-en-28-oicacid

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN008165","Ingredient_name": "3\u03b2-[(\u03b1-l-arabinopyranosyl)oxy]-19\u03b1-hydroxy-olean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14347","TCMID_id": "1579","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3β-[(α-l-arabinopyranosyl)oxy]-19α-hydroxy-urs-12-en-28-oicacid

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN008168","Ingredient_name": "3\u03b2-[(\u03b1-l-arabinopyranosyl)oxy]-19\u03b1-hydroxy-urs-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14352","TCMID_id": "1584","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-β-o-α-l-arabinopyranosyl jujubogenin

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN008280","Ingredient_name": "3-\u03b2-o-\u03b1-l-arabinopyranosyl jujubogenin","Alias": "NA","Ingredient_formula": "C35H56O8","Ingredient_Smile": "CC(=CC1CC(C2C3CCC4C5(CCC(C(C5CCC4(C36CC2(O1)OC6)C)(C)C)OC7C(C(C(CO7)O)O)O)C)(C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1574","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3beta-p-hydroxybenzoyldehydrotumtlosic acid

C38H52O6 (604.3764)

{"Ingredient_id": "HBIN008331","Ingredient_name": "3beta-p-hydroxybenzoyldehydrotumtlosic acid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3β-p-hydroxybenzoyldehydrotumulosicacid

C38H52O6 (604.3764)

{"Ingredient_id": "HBIN008332","Ingredient_name": "3\u03b2-p-hydroxybenzoyldehydrotumulosicacid","Alias": "NA","Ingredient_formula": "C38H52O6","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C5=CC=C(C=C5)O)C)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15813","TCMID_id": "9822","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-O-alpha-L-Arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid

C35H56O8 (604.3975)

{"Ingredient_id": "HBIN009068","Ingredient_name": "3-O-alpha-L-Arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid","Alias": "3-o-alpha-l-arabinopyranosyl-3 beta,23-dihydroxy-lup-20(29)-en-28-oic acid","Ingredient_formula": "C35H56O8","Ingredient_Smile": "Not Available","Ingredient_weight": "604.91","OB_score": "5.835593072","CAS_id": "NA","SymMap_id": "SMIT01113","TCMID_id": "30625","TCMSP_id": "MOL001958","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(2r,6r)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(1s,2r,8r,10r,11r,15s,16s,18r)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-10-hydroxy-2,7,7,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-18-yl (2r)-2-methylbutanoate

C34H52O9 (604.3611)

15-(acetyloxy)-10-hydroxy-5-(methoxycarbonyl)-5,9-dimethyl-2-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl 2,3-dimethyloxirane-2-carboxylate

C33H48O10 (604.3247)

3-{[(1r,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-hydroxy-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

3-{[11-(acetyloxy)-1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

6-[(3r,4s,5s,7r)-3-ethyl-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-5-methyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid

C35H56O8 (604.3975)

(3r,3as,5ar,5br,6r,7s,7ar,9s,11as,11br,12r,13ar,13bs)-12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(1s,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O8 (604.3975)

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-5-[(2s)-2-isopropyl-5-methylhex-4-en-1-yl]-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H52O6 (604.3764)

4a,6a,6b,11,11,14b-hexamethyl-2-(1,2,3,4-tetrahydroxybutyl)-2h,4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C35H56O8 (604.3975)

(2s,3s,4s,5r,6r)-4-{[(2s,3r,4r,5s,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate

C30H52O12 (604.3459)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2r,3r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

3-{[11-(acetyloxy)-1-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(2s)-1-[(2s)-2-[(2r)-2-{[(2s,3s)-1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

(4as,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2s)-n-[(2s)-1-[(2s)-2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl]-1-oxo-3-phenylpropan-2-yl]-2-[(2s)-2-(dimethylamino)-n,3-dimethylbutanamido]-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s,3s)-2-{[(2s)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

3-{[11-(acetyloxy)-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

16-(3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-7-en-2-yl)-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(3s,5r,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(3e,5e,7r,8s,9s,11e,13e,15s,16r)-16-[(2s,3r,4s,6e,8s,9r)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

(3r,3as,5ar,5br,6r,7s,7ar,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

3-{[11-(acetyloxy)-1-hydroxy-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

3-(acetyloxy)-15-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C35H56O8 (604.3975)

(3z,5e,7r,8s,9s,11e,13e,15s,16r)-16-[(2s,3r,4s,7e,9r)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-7-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

3-[(2r)-2-[(5-{[(2r)-4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl]methyl}-3-(3-methoxy-3-oxopropyl)-4-methyl-1h-pyrrol-2-yl)methyl]-5-{[(2r,3e,4s)-3-ethylidene-5-hydroxy-4-methyl-2,4-dihydropyrrol-2-yl]methyl}-4-methyl-2h-pyrrol-3-yl]propanoic acid

C34H44N4O6 (604.3261)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2r)-2-[(1r,2r,3ar,5ar,7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

3-{[(1s,3ar,3br,5ar,7r,9ar,9bs,11r,11as)-11-(acetyloxy)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(4ar,6as,6br,8ar,9s,10r,12ar,12br,14br)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2s,3r,4s,5s)-2-{[(1s,2r,5r,7s,10r,11r,14s,15s,16s,18r,20s)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxane-3,4,5-triol

C35H56O8 (604.3975)

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1r)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

(2s)-1-[(2s)-2-[(2s)-2-{[(2r,3r)-1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-(4-hydroxyphenyl)-n-methylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C32H52N4O7 (604.3836)

3-[2-({5-[(4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl)methyl]-3-(3-methoxy-3-oxopropyl)-4-methyl-1h-pyrrol-2-yl}methyl)-5-[(3-ethylidene-5-hydroxy-4-methyl-2,4-dihydropyrrol-2-yl)methyl]-4-methyl-2h-pyrrol-3-yl]propanoic acid

C34H44N4O6 (604.3261)

(4as,6as,6br,8ar,9r,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

3-{[(1r,3as,3br,5ar,7r,9ar,9br,11r,11as)-11-(acetyloxy)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

3-ethyl-6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxybenzoic acid

C35H56O8 (604.3975)

(3s)-3-[(2s,3r)-3-(acetyloxy)-1-[(2s)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]-3-{[(2s)-2-({1-hydroxy-2-[(1-hydroxy-2-methylpropylidene)amino]ethylidene}amino)-3-phenylpropanoyl]oxy}propanoic acid

C30H44N4O9 (604.3108)

(1s,2r,3ar,3br,5ar,6s,7s,9ar,9br,11ar)-2-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3a,3b,6,9a-tetramethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-6-carboxylic acid

C35H56O8 (604.3975)

(1s,2s,3r,5s,8r,9r,10r,14s)-2,5,9,10-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl 2-methylbutanoate

C33H48O10 (604.3247)

1-[5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

2-[(7s,9as,11ar)-2-hydroxy-7-(4-hydroxybenzoyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C38H52O6 (604.3764)

(4as,6ar,6br,8ar,9r,10s,12ar,12bs,14br)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

3-heptyl-5-hydroxyphenyl 2-heptyl-4-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C33H48O10 (604.3247)

(1r,3r,5r,6as,7s,8s,9r,10r,10as)-3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

(1s,2s,3r,8s,10s,11s,15r,16r)-3-(acetyloxy)-15-[(3r,5r,6r)-5-hydroxy-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(2s,3s,4s,5r,6r)-4-{[(2s,3r,4r,5r,6s)-3,5-bis(acetyloxy)-4-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-2-methyl-6-(octyloxy)oxan-3-yl hexanoate

C30H52O12 (604.3459)

2-{[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁵,²⁰]tricosan-7-yl]oxy}oxane-3,4,5-triol

C35H56O8 (604.3975)

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

n-(1-{[1-(2-benzyl-3-methoxy-5-oxo-2h-pyrrol-1-yl)-1-oxo-3-phenylpropan-2-yl](methyl)carbamoyl}-2-methylpropyl)-2-(dimethylamino)-n,3-dimethylbutanamide

C35H48N4O5 (604.3625)

n-(5-carbamimidamido-1-hydroxypentan-2-yl)-1-[(2s)-2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 2-methylbutanoate

C33H48O10 (604.3247)

3,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-1-yl butanoate

C33H48O10 (604.3247)

3-heptyl-5-hydroxyphenyl 2-{[(2s,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

(4as,6ar,6br,10s,12ar,14bs)-6a-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-10-hydroxy-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C38H52O6 (604.3764)

(1r,2s,4s,5r,8r,9s,10r,13r,15r)-15-(acetyloxy)-10-hydroxy-5-(methoxycarbonyl)-5,9-dimethyl-2-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-8-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate

C33H48O10 (604.3247)

1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

(1r,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

3-heptyl-5-hydroxyphenyl 2-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-6-heptyl-4-hydroxybenzoate

C33H48O10 (604.3247)

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,7r,9as,9bs,11as)-2-(acetyloxy)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-(acetyloxy)-2,3,4-trimethylpentyl acetate

C35H56O8 (604.3975)

7-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-6-hydroxy-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C33H48O10 (604.3247)

(1r,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

(1s,4ar,6as,6br,8as,10s,12ar,12br,14bs)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

n-(5-carbamimidamido-1-hydroxypentan-2-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

7-(acetyloxy)-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

(1r,2r,3s,8r,10r,11r,15s,16s)-3-(acetyloxy)-15-[(3s,5s,6s)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(3z,5e,7r,8s,9s,11z,15s,16r)-16-[(2s,3r,4s,6e,8s,9r)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O8 (604.3975)

(1r,3s,5s,6ar,7r,8r,9r,10s,10ar)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl 2-methylbutanoate

C33H48O10 (604.3247)

(1r,3r,5r,6as,7s,8s,9r,10r,10as)-1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

6-[(3r,4s,5s,7r)-7-[(2s,3s,5s)-3,5-diethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]oxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid

C35H56O8 (604.3975)

3-{[11-(acetyloxy)-1-(2,5-dihydroxy-6-methylhept-6-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(1r,3s,5s,6ar,7s,8r,9r,10s,10as)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2r)-2-methylbutanoate

C33H48O10 (604.3247)

(1r,3s,5s,6ar,7r,8r,9r,10s,10ar)-1,9-bis(acetyloxy)-3-(butanoyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl (2r)-2-methylbutanoate

C33H48O10 (604.3247)

(3r,4r,5s,6r)-6-{[(4e,6e,10e,14z,16e)-2,9-diethyl-12-hydroxy-5,7,11,17-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,10,14,16-pentaen-8-yl]oxy}-4,5-dihydroxy-2,2-dimethyloxan-3-yl acetate

C34H52O9 (604.3611)

9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C35H44N2O7 (604.3148)

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-6a-(hydroxymethyl)-1,2,6b,9,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O8 (604.3975)

10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(1r,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,10-bis(acetyloxy)-9-(butanoyloxy)-5-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C33H48O10 (604.3247)

9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O8 (604.3975)

6-[(3r,4s,5s,7r)-5-ethyl-7-[(2s,3s,5s)-5-ethyl-5-[(2r,5r,6s)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3-methyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid

C35H56O8 (604.3975)

(4as,6as,6br,8as,9r,10s,12ar,12br,14bs)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

1-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl 2-phenylacetate

C38H52O6 (604.3764)

(1r,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

7,9-dihydroxy-3a,5a,5b,11a-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C38H52O6 (604.3764)

9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

3-(acetyloxy)-15-(5,6-dihydroxy-7,7-dimethyloxepan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-10-yl acetate

C34H52O9 (604.3611)

6-[1-(9-hydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)

5-(acetyloxy)-5-[2-(acetyloxy)-7-hydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-2,3,4-trimethylpentan-2-yl acetate

C35H56O8 (604.3975)

(2s,4as,6as,6br,8ar,10r,12ar,12br,14br)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2,6a,6b,9,9,12a-hexamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-2-carboxylic acid

C38H52O6 (604.3764)

1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2r,4as,4br,6r,7r,10ar)-7-{[(2s,4s,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-6-hydroxy-4b-methyl-2-(2-methylfuran-3-yl)-2,3,4,4a,5,6,7,8,10,10a-decahydrophenanthren-1-one

C33H48O10 (604.3247)

(1s,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-1-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2r,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-hydroxypentan-2-yl]-1-[(2s)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H48N6O7 (604.3584)

(2r,6s)-2-{[(1r,3as,3br,7s,9ar,9bs,11as)-1-[(1s)-1-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

6a-(hydroxymethyl)-1,2,6b,9,9,12a-hexamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O8 (604.3975)

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s,5r)-2,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

(4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

3-heptyl-5-hydroxyphenyl 2-heptyl-4-hydroxy-6-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate

C33H48O10 (604.3247)

12-(acetyloxy)-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-6-yl benzoate

C38H52O6 (604.3764)

(1r,3as,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13br)-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-9-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C35H56O8 (604.3975)

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s,5s)-2,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O8 (604.3975)

2-[(1-{1-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]ethyl}-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl)oxy]-4-methoxy-6-methyl-2,6-dihydropyran-3-one

C34H52O9 (604.3611)

(3s,6r,10r,13e,16s)-9,12-dihydroxy-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(2r,3e)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C35H44N2O7 (604.3148)

10-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O8 (604.3975)

(2r,4ar,4br,6ar,6bs,8as,12as,14ar,14br,16as)-4a,6a,6b,11,11,14b-hexamethyl-2-[(1r,2s,3s)-1,2,3,4-tetrahydroxybutyl]-2h,4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C35H56O8 (604.3975)

3-(3-{2-hydroxy-6-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]hept-6-en-2-yl}-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,3ah,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl)propanoic acid

C35H56O8 (604.3975)

(6r)-6-[(1s)-1-[(1r,3as,3bs,7r,9s,9ar,9bs,11as)-9-hydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H52O9 (604.3611)